Versantis AG

Versantis develops a new generation of effective medicines and reliable diagnostics to revolutionize the care of patients with liver disease. Its lead candidate, VS-01, has the potential to fill the medical gap between preventive drugs and liver transplantations, and received Orphan Drug Designations from both the FDA and EMA. With a pipeline embracing a broad range of indications, Versantis aims to answer the unmet medical need of millions of people worldwide.

Versantis raised a CHF 4.4M series A in 2017 and has been rewarded with the most prestigious scientific and entrepreneurial prizes.

Job Offers

There are currently no job offers.

Keep an eye on this company by adding it to your watchlist.

Reviews

No reviews yet
Help other job seekers and be the first one to write a review.

Location

Versantis AG

Otto-Stern-Weg 7
8093 Zürich

http://www.versantis.ch/